Kongressthemen From Dissecting Mechanisms of Epithelial Dysfunction to Discovering Patient Reported Outcomes for More Meaningful Clinical Trials, Uncover Scientific Advancements and Actionable Insights to Optimize IPF Drug Development
Returning with a revitalized agenda including 25 brand new speakers, the hotly anticipated two-tracked summit is back!
Kongressorganizer (PCO) Hanson Wade
Anmerkungen Speakers: Andrei Gudkov Chief Science Officer Genome Protection, Andrew Thorley Fibrosis Therapeutic Area Lead - OMNI Biomarker Development Genentech, Anjaly Pandey Senior Vice President of Nonclinical and Chemistry twoXAR Pharmaceuticals and more
